Pathogen inactivation in labile blood products transfusion safety and economic impact - Discussion

被引：0
|
作者：
Bourel, Michel
Caen, Jacques
Dirreimer, Guy
Vacheron, Andre
Sansonetti, Philippe
Michel-Briand, Yvon
机构：
来源：
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE | 2006年 / 190卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：186 / 188
页数：3
相关论文
共 50 条
  • [41] Impact of amotosalen photochemical pathogen inactivation treatment (intercept blood system™) on the response to transfusion with 6 and 7-day old components
    Osselaer, J. C.
    Doyen, C.
    Defoin, L.
    Vandenbossche, S.
    Debry, C.
    Goffaux, M.
    Messe, N.
    Van, Hooydonk M.
    Corash, L. M.
    Lin, L.
    VOX SANGUINIS, 2008, 95 : 291 - 292
  • [42] Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system
    Cicchetti, Americo
    Coretti, Silvia
    Sacco, Francesco
    Rebulla, Paolo
    Fiore, A. Essandra
    Rumi, Filippo
    Di Bidino, Rossella
    Urbina, Luz, I
    Refolo, Pietro
    Sacchini, Dario
    Spagnolo, Antonio G.
    Midolos, Emanuela
    Marano, Giuseppe
    Farina, Blandina
    Pati, Ilaria
    Veropalumbo, Eva
    Pupella, Simonetta
    Liumbruno, Giancarlo M.
    BLOOD TRANSFUSION, 2018, 16 (06) : 483 - 489
  • [43] Economic Analyses of Pathogen-Reduction Technologies in Blood Transfusion: A Systematic Literature Review
    Patrick R. LaFontaine
    Jing Yuan
    Katherine M. Prioli
    Priti Shah
    Jay H. Herman
    Laura T. Pizzi
    Applied Health Economics and Health Policy, 2021, 19 : 487 - 499
  • [44] Economic Analyses of Pathogen-Reduction Technologies in Blood Transfusion: A Systematic Literature Review
    LaFontaine, Patrick R.
    Yuan, Jing
    Prioli, Katherine M.
    Shah, Priti
    Herman, Jay H.
    Pizzi, Laura T.
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2021, 19 (04) : 487 - 499
  • [45] Remuneration of blood donors and its impact on transfusion safety - Reply
    van der Poel, CL
    Seifried, E
    Schaasberg, W
    VOX SANGUINIS, 2003, 85 (01) : 50 - 51
  • [46] Economic analyses of blood safety and transfusion medicine interventions: A systematic review
    Custer, B
    TRANSFUSION MEDICINE REVIEWS, 2004, 18 (02) : 127 - 143
  • [47] Production of Standardized Labile Blood Products from a Single Whole Blood (WB) Donation at the EFS-Alsace Blood Center: Ten Years of Evolution and Impact of Inactivation Process
    Isola, H.
    Bigey, F.
    Kientz, D.
    Laforet, M.
    Gachet, C.
    Cazenave, J.
    TRANSFUSION, 2013, 53 : 96A - 96A
  • [48] Five Years with Pathogen Inactivation As a New Standard of Care for Blood Safety: The Honduras Experience
    Marcelo Pedraza, Rolando
    TRANSFUSION, 2022, 62 : 173A - 173A
  • [49] Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products
    Goodrich, Raymond P.
    Doane, Suzann
    Reddy, Heather L.
    BIOLOGICALS, 2010, 38 (01) : 20 - 30
  • [50] Combining Apheresis and Pathogen Reduction Standardizes Platelet Products and Enhances Blood Safety
    Sevcik, H.
    Hoecker, P.
    TRANSFUSION, 2012, 52 : 71A - 71A
12345